Core Points - The China Colorful Undertaking Promotion Association held its seventh member representative conference, where Shen Ying was elected as president and Chen Bang, chairman of Aier Eye Hospital Group, was recognized for his contributions to public welfare [2] - Aier Eye Hospital's "cross-subsidy" public welfare model supports sustainable development by using profits from high-end medical services to subsidize low-income eye disease patients, aligning with the core philosophy of the Colorful Undertaking [3] - Aier Eye Hospital aims for equal access to medical services in urban and rural areas, establishing a three-tier eye health public health service system and enhancing grassroots medical capabilities through donations and training [4] - The company has supported 873 public welfare projects across 31 provinces and regions in China, receiving the "Chinese Charity Award" for three consecutive terms [5] Summary by Sections Organizational Developments - The seventh council of the China Colorful Undertaking Promotion Association was elected, with 22 vice presidents and 136 executive directors appointed, highlighting the recognition of Aier Eye Hospital's commitment to public welfare [2] Public Welfare Initiatives - Aier Eye Hospital has developed a comprehensive eye health care system targeting vulnerable groups, including the elderly, children, and disabled individuals, through various public welfare actions [3] - The company has invested over 13.62 million yuan in establishing 592 eye health workstations and training 846 grassroots doctors, enhancing the accessibility of eye care services [4] Achievements and Recognition - Aier Eye Hospital's efforts in public welfare have led to its recognition as a model for private enterprises, with a commitment to combining "blood transfusion" and "blood production" in its charitable actions [5]

Group 1 - The 2025 World Artificial Intelligence Conference concluded successfully in Shanghai, where Aier Eye Hospital was awarded the "Local Innovation Internationalization Case" for its leading digital ophthalmology technology and continuous innovation capabilities [1] - Aier Eye Hospital has established a global presence with 974 hospitals, eye centers, and clinics, including 811 in mainland China, contributing to the development of ophthalmology and visual science [3] - The company emphasizes innovation as a key driver for high-quality development, investing in research and development while integrating medical, education, research, production, and investment strategies [3] Group 2 - Aier Eye Hospital prioritizes medical quality and safety management, implementing a systematic quality control system and deepening digital transformation to meet diverse patient needs [4] - The company aims to synchronize medical technology, equipment, and pharmaceuticals with international standards, enhancing global access to innovative technologies [4] - Aier Eye Hospital has pioneered a "digital ophthalmology" model, advancing the digital and intelligent transformation of ophthalmic medical services [4] Group 3 - Leveraging extensive data from its global network, Aier Eye Hospital has established a comprehensive eye health big data center and developed various self-researched medical systems to enhance service delivery [5] - Key projects include optimizing AI management systems for fundus examinations and expanding intelligent screening tools for eyelid tumors [5] - The company is committed to its mission of ensuring eye health access for all, regardless of socioeconomic status, and aims to build a world-class ophthalmology center through its "1+8+N" development strategy [5]